|
|
||||||||
J Thorac Cardiovasc Surg 2002;124:404-406
© 2002 The American Association for Thoracic Surgery
Brief Communications |
From the Departments of Thoracic Surgerya and Histopathology,c Royal Brompton Hospital, London, and Department of Clinical Pharmacology,b Royal Marsden Hospital, London, United Kingdom.
Received for publication Nov 24, 2001. Accepted for publication Dec 10, 2001. Address for reprints: Mr G. Ladas, Consultant Thoracic Surgeon, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, United Kingdom (E-mail: g.ladas{at}rbh.nthames.nhs.uk).
A 33-year-old nonsmoker had an 8-month history of hemoptysis. He was otherwise well, with normal hematologic and biochemical indices, and his medical history was unremarkable. Fiberoptic bronchoscopy elsewhere showed external compression of the airway, consistent with a mediastinal mass, but no endobronchial lesions. Biopsy specimens showed capillary proliferation in the subepithelial stroma but no cytologic features of malignancy. The possibility of a benign or low-grade vascular neoplasm was raised. After the biopsy, the patient had a massive hemoptysis necessitating blood transfusion. Subsequent contrast computed tomographic and magnetic resonance imaging scans demonstrated an extensive mediastinal mass of high vascularity, which extended from above the level of the azygos arch to the left atrium inferiorly. The tumor also encased the carina, esophagus, and several major blood vessels within the mediastinum (Figure 1, A and B). On examination with a rigid bronchoscope, there was profuse arterial bleeding at the biopsy site from the left main bronchus and evidence of further recent bleeding distally. Hemostasis was secured by cauterizing the arterial bleeding point with a diathermy loop. Because of uncertainty over the histologic diagnosis and degree of malignancy, cervical mediastinoscopy was also undertaken, which showed paratracheal and subcarinal tissues infiltrated by a vascular mass containing several large tortuous arteries. Biopsy showed similar features to the bronchial biopsy, with lobules of cytologically benign capillaries infiltrating mediastinal soft tissues. A vascular phenotype was confirmed by positive immunohistochemical staining for CD34 and factor 8, and a diagnosis of capillary hemangioma was made (Figure 2, A).
|
|
Discussion
Tumors of vascular origin usually appear in childhood. Common locations include subcutaneous tissue, liver, bone, central nervous system, and spleen. Isolated mediastinal localization is rare and accounts for fewer than 2% of all mediastinal tumors.
1,2 Vascular tumors comprise a wide spectrum of histopathologic entities ranging from benign hemangiomas, through low-grade malignant tumors such as capillary hemangiomas, up to overtly malignant angiosarcomas.
3
Symptoms in patients with mediastinal hemangioma are related to compression or invasion of adjacent structures and may include symptoms of airway obstruction or dysphagia. Other rare presentations include superior vena cava obstruction, vocal cord paralysis, spontaneous hemothorax, or significant hemoptysis that may even require blood transfusion, as described in this case.
4 Complete surgical resection remains the optimal treatment.
3,4 but resection is considered extremely hazardous in patients with extensive involvement of mediastinal structures. Nevertheless, even incomplete resection has been advocated by some authors.
2
Alpha-2a interferon is a highly purified recombinant DNA product and is a potent angiogenesis inhibitor that acts by blocking the action of basic fibroblast growth factor. In the proliferative phase, hemangiomas are characterized by endothelial cell migration and proliferation, and basic fibroblast growth factor is a major stimulus for this proliferation. It is therefore believed that alpha-2a interferon inhibits endothelial cell proliferation by blocking the actions of basic fibroblast growth factor,
5 and there is considerable experience with its use in children with hemangiomas at different sites including life-threatening airway hemangioma.
6
However, very little experience with alpha-2a interferon has been reported in adults, especially relating to mediastinal hemangiomas, and this case documents both a significant clinical response in this age group and a reduction of tumor bulk to a degree that enabled complete resection of a tumor initially considered inoperable. However, although alpha-2a interferon led to marked symptomatic benefit without any side effects in this case, neurologic, cardiac, and visual side effects are frequently reported in children.
6
It is also interesting to note the change in tumor morphology after chemotherapy, with an absence of the capillary proliferation seen on the initial bronchoscopic and mediastinal biopsies and replacement by dense fibrosis, while the larger feeding vessels remained. This suggests that inhibition of basic fibroblast growth factor leads to preferential regression or inhibition of the endothelial cells in the areas of capillary proliferation.
In conclusion, use of alpha-2a interferon may represent a significant step forward in the management of such vascular tumors, especially in situations in which the tumor is initially considered to be inoperable.
References
This article has been cited by other articles:
![]() |
P. Kumar, G. P. Ladas, I. Judson, and A. G. Nicholson Epithelioid hemangioendothelioma and other vascular mediastinal tumors: a role for alpha-2a interferon? Ann. Thorac. Surg., August 1, 2003; 76(2): 653 - 653. [Full Text] [PDF] |
||||
![]() |
S. Hasegawa, N. Isowa, and H. Wada Reply to the editor Ann. Thorac. Surg., August 1, 2003; 76(2): 653 - 653. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |